The pharmaceutical industry relies heavily on a diverse array of chemical intermediates to synthesize life-saving medications. Among these, 2-methoxyphenyl salicylate (CAS 87-16-1) holds a significant position. This fine chemical, often referred to by synonyms like Guaiacol salol, serves as a vital building block in the intricate pathways of pharmaceutical synthesis. Understanding its properties and how to procure it reliably is key for any R&D scientist or procurement manager in this sector.

As a pharmaceutical intermediate, the purity and consistent quality of 2-methoxyphenyl salicylate are non-negotiable. Our company, a dedicated manufacturer and supplier of chemicals from China, ensures that our product meets the exacting standards required for pharmaceutical applications. We understand that researchers and manufacturers need dependable access to materials like CAS 87-16-1 to maintain the integrity of their synthesis processes and the safety of their final products.

The synthesis of 2-methoxyphenyl salicylate itself is a chemical process that requires precise control over reaction conditions. While specific details are proprietary, the general approach involves esterification. For those looking to buy 2-methoxyphenyl salicylate, engaging with a manufacturer that can offer technical support and detailed product documentation adds significant value. This allows formulators and chemists to confidently integrate the intermediate into their workflow.

The applications of 2-methoxyphenyl salicylate extend across various therapeutic areas, often as a precursor to more complex molecules with specific biological activities. Its structural features make it amenable to a range of chemical modifications, enabling the creation of novel compounds. If your research or production involves this intermediate, consider the benefits of sourcing directly from a manufacturer in China. This often translates to better pricing, direct access to the production team, and a more agile supply chain, ultimately supporting your goal of bringing innovative pharmaceuticals to market.